Option Care Health (NASDAQ:OPCH) Hits New 12-Month Low – Should You Sell?

Shares of Option Care Health, Inc. (NASDAQ:OPCH) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $21.54 and last traded at $21.54, with a volume of 3973 shares. The stock had previously closed at $21.74.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and reduced their price target for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Truist Financial reduced their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Barrington Research cut their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. Finally, JMP Securities lifted their price objective on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a report on Monday, September 30th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, Option Care Health has a consensus rating of “Moderate Buy” and a consensus target price of $30.83.

Option Care Health Stock Performance

The firm has a market cap of $3.72 billion, a price-to-earnings ratio of 18.39, a P/E/G ratio of 2.27 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a fifty day simple moving average of $27.98 and a two-hundred day simple moving average of $29.21.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction on Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is owned by company insiders.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors have recently modified their holdings of OPCH. CANADA LIFE ASSURANCE Co grew its holdings in Option Care Health by 1.8% during the first quarter. CANADA LIFE ASSURANCE Co now owns 134,305 shares of the company’s stock worth $4,503,000 after acquiring an additional 2,355 shares during the period. CreativeOne Wealth LLC grew its stake in shares of Option Care Health by 24.9% during the 1st quarter. CreativeOne Wealth LLC now owns 10,885 shares of the company’s stock worth $365,000 after purchasing an additional 2,173 shares during the period. Magnetar Financial LLC grew its stake in shares of Option Care Health by 11.7% during the 1st quarter. Magnetar Financial LLC now owns 1,104,006 shares of the company’s stock worth $37,028,000 after purchasing an additional 115,768 shares during the period. Hood River Capital Management LLC increased its holdings in shares of Option Care Health by 6.3% during the 1st quarter. Hood River Capital Management LLC now owns 975,821 shares of the company’s stock valued at $32,729,000 after purchasing an additional 57,568 shares in the last quarter. Finally, BOKF NA lifted its stake in shares of Option Care Health by 13.5% in the 1st quarter. BOKF NA now owns 47,139 shares of the company’s stock valued at $1,546,000 after purchasing an additional 5,589 shares during the period. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.